These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 25294570

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Neuromyelitis optica].
    Kvistad SA, Wergeland S, Torkildsen Ø, Myhr KM, Vedeler CA.
    Tidsskr Nor Laegeforen; 2013 Oct 15; 133(19):2057-61. PubMed ID: 24129537
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
    Kitley J, Elsone L, George J, Waters P, Woodhall M, Vincent A, Jacob A, Leite MI, Palace J.
    J Neurol Neurosurg Psychiatry; 2013 Aug 15; 84(8):918-21. PubMed ID: 23467418
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
    Altintas A, Karabudak R, Balci BP, Terzi M, Soysal A, Saip S, Tuncer Kurne A, Uygunoglu U, Nalbantoglu M, Gozubatik Celik G, Isik N, Celik Y, Gokcay F, Duman T, Boz C, Yucesan C, Mangan MS, Celebisoy N, Diker S, Colpak Isikay I, Kansu T, Siva A.
    Neurologist; 2015 Oct 15; 20(4):61-6. PubMed ID: 26468870
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
    Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.
    Brain; 2007 May 15; 130(Pt 5):1235-43. PubMed ID: 17449477
    [Abstract] [Full Text] [Related]

  • 10. A case of chronic progressive myelopathy.
    Kim JS, Park YH, Kim SM, Kim SH, Park KS, Sung JJ, Lee KW.
    Mult Scler; 2010 Oct 15; 16(10):1255-7. PubMed ID: 20798133
    [Abstract] [Full Text] [Related]

  • 11. [Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].
    Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.
    Rinsho Byori; 2009 Mar 15; 57(3):262-70. PubMed ID: 19363997
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intermittent plasmapheresis prevents recurrence in neuromyelitis optica.
    Miyamoto K, Kusunoki S.
    Ther Apher Dial; 2009 Dec 15; 13(6):505-8. PubMed ID: 19954473
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel advances in the diagnosis and treatment of neuromyelitis optica: is there a need to redefine the gold standard?
    de Seze J, Collongues N.
    Expert Rev Clin Immunol; 2013 Oct 15; 9(10):979-86. PubMed ID: 24128159
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.